Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Familial combined hyperlipidemia (FCHL) in children: the significance of early development of hyperapoB lipoproteinemia, obesity and aging.

Journal of atherosclerosis and thrombosis - 1 Jan 2002

Kuromori Yuki, Okada Tomoo, Iwata Fujihiko, Hara Mitsuhiko, Noto Nobutaka, Harada Kensuke

Abstract excerpt

It is not easy to make diagnose FCHL in children, since a clear expression of lipoprotein abnormality is unlikely and standard criteria have not yet been established. We investigated eight cases of childhood FCHL and their families with respect to familial history, anthropometric parameters and serum lipoprotein levels, to explore the characteristics of childhood FCHL. To diagnose childhood FCHL it is necessary...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Apolipoprotein A-I
Share to Apolipoproteins B

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Apolipoproteins E

Share to Child Development

Share to Cholesterol, HDL

Share to Cholesterol, LDL

Share to Hyperlipidemia, Familial Combined

Share to Receptors, LDL

Source

Identifiers

PMID: 12560593
DOI: 10.5551/jat.9.314

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Familial combined hyperlipidemia (FCHL) in children: the significance of early development of hyperapoB lipoproteinemia, obesity and aging.PMID 12560593Read ↗

Molecular mechanisms, prevalence, and molecular methods for familial combined hyperlipidemia disease: A reviewSemantic proximity Read ↗

Familial combined hyperlipidemia in children: clinical expression, metabolic defects, and management.Semantic proximity Read ↗

Effect of aging and obesity on the expression of dyslipidaemia in children from families with familial combined hyperlipidaemia.Semantic proximity Read ↗

Familial combined hyperlipidemia: An overview of the underlying molecular mechanisms and therapeutic strategiesSemantic proximity Read ↗

Monogenic pediatric dyslipidemias: classification, genetics and clinical spectrum.Semantic proximity Read ↗

Atherogenic dyslipidemia in children: evaluation of clinical, biochemical and genetic aspects.Semantic proximity Read ↗

Screening for familial combined hyperlipidemia in children using lipid phenotypes.Semantic proximity Read ↗

Heterozygous Familial Hypobetalipoproteinemia in Children and Adolescents: Time and tide wait for no manSemantic proximity Read ↗

[Familial combined hyperlipidemia: detection and characterisation of the hyperlipidemic profile among children and adolescents].Semantic proximity Read ↗

Case Studies in Pediatric Lipid Disorders and Their Management.Semantic proximity Read ↗

Genetic dissection of familial combined hyperlipidemia.Semantic proximity Read ↗

Familial combined hyperlipoproteinemia: experts panel position on diagnostic criteria for clinical practice. Committee of experts of the Atherosclerosis and Dysmetabolic Disorders Study Group.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.